Verastem

Forecast & Rating10 analysts currently cover Verastem, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.67, about 91.0% upside from the current price of $7.68. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 9.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Verastem closely still see room for the stock to rise. Data as of Sep 17, 2026; for reference only and not investment advice.